Kriya Therapeutics, Inc. Tech Stack
Gene therapy developer advancing treatments in ophthalmology, metabolic disease, and neurology
Kriya is a gene-therapy company founded in 2019 and headquartered across Research Triangle Park and Palo Alto. The tech stack reveals a manufacturing and regulatory operations focus: NONMEM, OSIsoft PI, DeltaV, Allen-Bradley, and SCADA systems dominate, paired with Python/pandas data analysis and AWS. Active hiring across clinical, regulatory, and research roles—with director-and-VP-level positions open—signals scaling toward IND/clinical submissions and manufacturing validation. Current projects center on post-marketing surveillance, analytical method development, aseptic process simulation, and regulatory dossier preparation, consistent with mid-stage biopharmaceutical execution.
Tech Stack 28 technologies
What Kriya Therapeutics, Inc. Is Building
◆Challenges
- Process transfer gmp
- Vendor selection and performance management
- Ensuring data quality and regulatory compliance
- Managing safety surveillance
- Safety data management
- Aseptic process simulation
- Enhancing facility reliability
- Maximizing uptime
- Maintaining compliance
- Regulatory change monitoring
▲Active Projects
- Post-marketing surveillance
- Aav analytical method development
- Prepare and submit periodic safety update reports
- Aseptic process simulation program
- Psur submission process
- Enterprise-level cro strategy
- Clinical operational excellence initiatives
- Portfolio-level site management
- Global regulatory dossier preparation
- Process validation protocols
Hiring Activity
Department
Seniority
Notable leadership hires: Pharmacovigilance Director